Ketek clinical study fraud :
what did Aventis know? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, February 12, 2008.

Description

Corporate Author

United States. Congress.

Language(s)

English

Published

Washington : U.S. G.P.O. : 2008.

Subjects

Drug approval > Drug approval / United States.
Clinical trials > Clinical trials / Corrupt practices > Clinical trials / Corrupt practices / United States.
Antibiotics > Antibiotics / Testing > Antibiotics / Testing / Corrupt practices > Antibiotics / Testing / Corrupt practices / United States.
Telithromycin > Telithromycin / Testing > Telithromycin / Testing / Corrupt practices > Telithromycin / Testing / Corrupt practices / United States.

Note

"Serial no. 110-87."
Shipping list no.: 2009-0323-P.

Physical Description

iii, 187 p. ; 24 cm.

ISBN

0160832403
9780160832406

Locate a Print Version

Find in a library

Viewability